Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply.
Saved in:
| Title: | Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply. |
|---|---|
| Authors: | Al-Ani AH; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Vic., Australia., Prentice RE; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Vic., Australia., Rentsch C; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Vic., Australia., Christensen B; Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Vic., Australia. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (6), pp. 766-767. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.16287 |
